 chemotherapi metastat and/or recurr undifferenti nasopharyng carcinoma cisplatin bleomycin fluorouracil nasopharyng carcinoma ucnt radiosensit chemosensit latter phase II methodolog intens work-up patient recurr rec metastat mt ucnt monthli cycl cisplatin cddp day mg IV day continu infus CI day CI day pbf patient north african sex ratio male femal median world health organ who perform statu patient assess respons complet respons cr partial respons pr overal respons rate confid interv assess group global rate cr group previou chemotherapi patient CR chemotherapi group patient patient aliv evid diseas month bone mt radiat therapi site result chemosensit ucnt observ unmaintain long-term respond curabl possibl consider